The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Freezing of Gait Program, 2025Treating Freezing of Gait in Parkinson’s Disease Using an ADHD Drug that Reduces Neural Cross-talk: A Multi-center Multi-modal Approach
Study Rationale: Freezing of gait affects four out of five people with Parkinson’s disease (PD), yet this debilitating symptom is not fully treated by any PD medication available. Research has shown...
-
Parkinson’s Disease Therapeutics Pipeline Program, 2025Assessment of Psilocybin Therapy for Treatment of Depression in Parkinson’s Disease
Study Rationale: Depression is of the most common and disabling symptoms of Parkinson’s disease (PD), and it is linked to poor quality of life and faster disease progression. Unfortunately, we lack...
-
Accelerating Biological Understanding and Therapeutic Translation for PD-Biology, 2025Investigating the Mechanisms of Alpha-synuclein-induced Anxiety in a Novel Preclinical Model of Parkinson’s Disease
Study Rationale: Although Parkinson’s disease (PD) is known as a movement disorder, non-motor symptoms like anxiety can severely reduce individuals’ quality of life. Unfortunately, we know very little...
-
Parkinson’s Disease Therapeutics Pipeline Program, 2025(SUPPLEMENT) Discovery of Translational Biomarkers for Endolysosomal Pathway Pathology Using Lipidomics and Metabolomics
Study Rationale: The endolysosomal system in living cells is comprised of small, specialized structures that contain enzymes that degrade proteins and remove molecular waste. Impaired function of this...
-
ASAP CRN Competitive Renewal Opportunity, 2025Examining the Dual Role of Neural Activity in Parkinson’s Disease
Study Rationale: Most previous work on brain circuitry in Parkinson’s disease (PD) has focused on what happens after the loss of dopamine neurons. However, we know that changes in the function of...
-
Accelerating Biological Understanding and Therapeutic Translation for PD-Biology, 2025Targeting Mitochondrial Complex I in Parkinson’s Disease
Study Rationale: Three of the primary risk factors for Parkinson's disease (PD)—aging, environmental toxins and genetic mutations—all lead to impaired function of mitochondria, structures that...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.